Speaker: Christine Lu, an associate professor and co-director at the Precision Medicine Translational Research centre & Joe Kimura, the Chief Medical Officer at Atrius Health
Writer: Christiane Zhao
Christine Lu, an associate professor and co-director at the Precision Medicine Translational Research centre, give her opinions based upon on the public health sites of Precision Medicine. "Precision is not just about using genomic; it is trying to reunite patient preference in care delivery and the outcome of care." Precision medicine is increasingly used in life; it widely appears in clinical settings and used for consumer genomic testing as well. She then pointed out three main challenges that the U.S. market is facing. First of all, there is a lack of clear evidence to support the implication of precision medicine, even though we have various use of precision medicine. We do not have enough substantial and robust evidence to show that the use of technology in genomics can make a real difference to our daily life. The reason for that is mainly because the human genome is not complete, while how to categories different genomic sequences and distinct understanding of genomic can change the output. Clinicians and patients should be more informed with the update. However, the system makes it very difficult to ensure the updates is on time before the decision-making point in the clinics. Secondly, we do not have a comprehensive policy and governance for privacy. While lots of information that are related to genomics are new and data computation is needed, we are urgently to develop the law to prevent unsuspected use of this information. Government accessed data might be used by employer or insurance companies, which can reinforce the role of discrimination in society. Lastly, the cost of genomic tests are reducing, but the variation of products is enormous. We have inequality and disparity between the quality of the test result, but we do not have an excellent solution to deal with these yet.
Joe Kimura, the Chief Medical Officer at Atrius Health, is then picked up the talk. He said that 80% of the new practice care comes from capitation domain, which brings the concern of driving the most value from the daily practice. It is necessary to create a learning healthcare system, as we are acknowledged that we do not know the blueprint of the future of healthcare. The current healthcare system requires a long cycle time frame for the medicare givers to learn and adopt changes. Joe also pointed out that the adoption of health informatics can solve inequalities in access to care, especially in primary care.
"What is the optimal form of leadership?" Joe continues to explain, "The best primary care physician enables a patient to believe they are taking control of their health. Technology gives patients the ability to engage in their health also enables care providers to involve in the care delivery process actively." The United States is having an ageing demographics as well as a lack of healthcare staff. Therefore, we should support patients' independence in health, but also enhance the bonds between the patient and the system. Evidence-based care is an essential part of achieving this. It means the appropriate uses of technology can enable patient to know their health better, for instance, home care. It will always be difficult for care providers to adopt the changes between 20 years ago, now and 20 years later, but it is so essential to create values for access to care, access to continuous care.
Declaimer: This article is generated based on a talk given at the 9th US-CHina Health Summit in Boston, the United States in 26th September 2019. The views and opinions expressed in this article only reflect the speaker’s opinion and does not necessarily reflect the author’s official policy or position. All rights reserved.